Publication | Closed Access

Relation of ADRB1, CYP2D6, and UGT1A1 Polymorphisms With Dose of, and Response to, Carvedilol or Metoprolol Therapy in Patients With Chronic Heart Failure

Metoprolol TherapyCardiomyopathyHeart FailureChronic Heart FailureUgt1a1 PolymorphismsCardiovascular DiseaseMedicineAtherosclerosisCardiovascular PharmacologyPharmacotherapyCardiac CarePharmacologyCardiologyCardiovascular Genetics